Cancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing.
Prisca Olabisi AdejumoToyin I G AniagwuOlutosin Alaba AwoludeBabatunde AdedokunMakayla KochheiserAnthonia SowunmiAbiodun PopoolaOladosu OjengbedeDezheng HuoOlufunmilayo I OlopadePublished in: JCO global oncology (2023)
Learning clinically relevant details toward cancer prevention informs health-related decisions in patients and relatives, a motivator for willingness to pay for genetic testing in low- and middle-income countries. Increased awareness may influence outcomes of cancer risk management.
Keyphrases
- papillary thyroid
- end stage renal disease
- squamous cell
- ejection fraction
- newly diagnosed
- mental health
- chronic kidney disease
- primary care
- health insurance
- prognostic factors
- gene expression
- squamous cell carcinoma
- peritoneal dialysis
- genome wide
- childhood cancer
- oxidative stress
- metabolic syndrome
- young adults
- patient reported
- glycemic control
- weight loss